On April 26, 2024, the San Francisco-based startup that uses artificial intelligence to assist drug discoveryYoneda Labsannounced it has raised $4 million in seed funding. The round was led by Khosla Ventures, with participation from investors including 500 Emerging Europe, 468 Capital, and Y Combinator.
The company plans to use the raised funds to purchase the necessary robotic automation equipment to run chemical reactions in its laboratory, thereby generating training data for the company's models.
Yoneda Labs was founded in 2023 by Michal Mgeladze-Arciuch, Daniel Vlasits, and Jan Oboril, aiming to develop foundation models for chemical manufacturing. The company uses artificial intelligence to tell chemists how to make new drugs, in order to accelerate the creation of new drugs and reduce the cost of chemical manufacturing.
(Source:VentureBeat）